Long Term effects of Y90 | Dr. Ishita B Sen

Y90 or Yttrium 90 is a very potent radioisotope which is used to treat liver tumors and this may be labeled with a spheres and which are used in patients with Hepatocellular carcinoma or in certain metastasis sometimes also in neuroendocrine tumors or they may be labeled with somatostatin receptor analog like dotatoc or dotatate and in such situation, this is called Y90 PRRT. Now Y90 PRRT may be used either by itself or it may be used along with Lutetium Therapy in alternating kind of protocol so you give one dose of Lutetium PRRT followed by a dose of Y90 again followed by Lutetium Therapy along with next dose as Y90. So this is called Tandem Therapy and this is very effective in patients who’ve got a large volume diseases.

Note:
The content provided on this video is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

For More Info do Visit - https://nuclearmedicinetherapy.in
You can Chat with Dr. Ishita on your issue at her Facebook Group -   / 443181646702663  

Also Do Check: Nuclear Medicine Therapy for Treatment of Lymphoma? | Dr. Ishita B. Sen | FMRI at    • Lu177 PRRT For Neuroendocrine Tumors ...  
Cancer Care During Covid-19 by Dr. Ishita B. Sen MBBS, DRM,DNB (Nuclear Medicine) at    • Cancer Care During Covid-19 | Dr. Ish...  

Follow our other social channels

Facebook:   / nuclearmedicinetreatment  
​
Twitter:   / therapynuclear  
​
Instagram:   / nuclearmedicinetreatment  
​
LinkedIn:   / nuclear-medicine-therapy  

#NuclearMedicineTherapy​
#Lu177PRRT
#TandemTherapy
#Y90

Music: https://www.bensound.com